Rodica Heredea
Biographic Data
| ID | 8255501 |
|---|---|
| NAME | Rodica Heredea |
| GIVEN NAMES | Rodica |
| FAMILY NAME | Heredea |
| SIGNATURE | HEREDEA R |
| AFFILIATIONS | Victor Babeș University of Medicine and Pharmacy Timișoara |
| ORCID | 0000-0001-7634-4297 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The Molecular and Histopathological Assessment of Inflammatory Status in Very and Extremely Premature Infants
Prematurity comes with a varying range of complications, implying a high prevalence of complications and mortality and depending on the severity of prematurity and the sustained inflammation among these infants, which recently sparked an important scientific interest. The primary objective of this prospective study was to establish the degree of inflammation in very (VPIs) and extremely preterm infants (EPIs) in association with the histology fin…
Face(s)” of a PHACE(S) Syndrome Patient before and after Therapy
A rare, uncommon disorder called PHACE(S) (P-posterior fossa anomalies, H-hemangioma, A-arterial anomalies, C-cardiac anomalies, E-eye anomalies, and S-sternal cleft) of unknown etiology was rarely reported. Children are susceptible to developing PHACE(S) syndrome from the moment they are born. It may be challenging for a physician to appropriately diagnose and treat children with PHACE due to the multifaceted nature of the disease and the extens…
Vegf Pathway Gene Expression Profile of Proliferating versus Involuting Infantile Hemangiomas
Background . Infantile hemangiomas may have unexpected behavior. Initial regression (spontaneously or drug-induced) may be followed by unexplained recurrences. At this moment, there are no well-established criteria to predict infantile hemangioma reccurrences. Methods . We compared the VEGF pathway gene expression profile for one case of involuting infantile hemangioma versus one case of recurrent proliferative infantile hemangioma using TaqMan A…
No prominent works on this page.
Face(s)” of a PHACE(S) Syndrome Patient before and after Therapy
A rare, uncommon disorder called PHACE(S) (P-posterior fossa anomalies, H-hemangioma, A-arterial anomalies, C-cardiac anomalies, E-eye anomalies, and S-sternal cleft) of unknown etiology was rarely reported. Children are susceptible to developing PHACE(S) syndrome from the moment they are born. It may be challenging for a physician to appropriately diagnose and treat children with PHACE due to the multifaceted nature of the disease and the extens…
Vegf Pathway Gene Expression Profile of Proliferating versus Involuting Infantile Hemangiomas
Background . Infantile hemangiomas may have unexpected behavior. Initial regression (spontaneously or drug-induced) may be followed by unexplained recurrences. At this moment, there are no well-established criteria to predict infantile hemangioma reccurrences. Methods . We compared the VEGF pathway gene expression profile for one case of involuting infantile hemangioma versus one case of recurrent proliferative infantile hemangioma using TaqMan A…
The Molecular and Histopathological Assessment of Inflammatory Status in Very and Extremely Premature Infants
Prematurity comes with a varying range of complications, implying a high prevalence of complications and mortality and depending on the severity of prematurity and the sustained inflammation among these infants, which recently sparked an important scientific interest. The primary objective of this prospective study was to establish the degree of inflammation in very (VPIs) and extremely preterm infants (EPIs) in association with the histology fin…
Medicine (3 works) · Biology (2 works) · Hemangioma (2 works) · Internal Medicine (2 works) · Pediatrics (2 works) · Tumors and Oncological Cases (2 works) · Vascular Malformations and Hemangiomas (2 works) · AKT1 (1 work) · Cancer Research (1 work) · Concomitant (1 work)